Connect Biopharma Holdings Limited
CNTB
$2.65
-$0.01-0.38%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -66.67% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -66.67% | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -66.67% | -- | |||
| SG&A Expenses | 40.09% | -2.39% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 31.33% | 17.69% | |||
| Operating Income | -31.68% | -17.27% | |||
| Income Before Tax | -33.44% | -25.70% | |||
| Income Tax Expenses | 10.91% | 1.85% | |||
| Earnings from Continuing Operations | -33.34% | -25.57% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -33.34% | -25.57% | |||
| EBIT | -31.68% | -17.27% | |||
| EBITDA | -32.03% | -17.55% | |||
| EPS Basic | -32.83% | -25.22% | |||
| Normalized Basic EPS | -32.99% | -25.30% | |||
| EPS Diluted | -32.83% | -25.22% | |||
| Normalized Diluted EPS | -32.99% | -25.30% | |||
| Average Basic Shares Outstanding | 0.39% | 0.26% | |||
| Average Diluted Shares Outstanding | 0.39% | 0.26% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||